The Cooper Companies said revenue for its fiscal third quarter ended July 31, 2025 increased 6% year-over-year to $1,060.3 million, with CooperVision revenue up 6% to $718.4 million and CooperSurgical revenue up 4% to $341.9 million.

1. 01

   The Cooper Companies said revenue for its fiscal third quarter ended July 31, 2025 increased 6% year-over-year to $1,060.3 million, with CooperVision revenue up 6% to $718.4 million and CooperSurgical revenue up 4% to $341.9 million.

2. 02

   The company reported fiscal third quarter GAAP gross margin of 65% compared with 66% in the prior-year quarter, operating margin of 17% compared with 19%, and GAAP diluted EPS of $0.49 compared with $0.52. Non-GAAP diluted EPS was $1.10 compared with $0.96.

3. 03

   The Cooper Companies said that in the fiscal third quarter, cash provided by operations of $261.5 million offset by capital expenditures of $96.9 million resulted in free cash flow of $164.6 million. Free cash flow is a non-GAAP measure defined as cash provided by operating activities less capital expenditures.

4. 04

   The company provided updated fiscal 2025 guidance of total revenue $4,076 to $4,096 million and non-GAAP diluted EPS $4.08 to $4.12. For the fiscal fourth quarter, it guided to total revenue $1,049 to $1,069 million and non-GAAP diluted EPS $1.10 to $1.14.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.